DIRECT BIOLOGICS LLC

In News

Direct Biologics Announces Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Clinical Trial - BioInformant

BioInformant - Jul 13, 2023

Direct Biologics’ Phase 1 Clinical Trial Seeks to Treat Crohn Disease With Extracellular Vesicles - CGTLive®

CGTLive® - Dec 04, 2023

Acute Respiratory Distress Syndrome Market to Grow Steadily - GlobeNewswire

GlobeNewswire - Jun 03, 2026

Houston-based SPAC Good Works II aims to take Austin-based Direct Biologics public - The Business Journals

The Business Journals - Sep 29, 2022

Rapid Micro Biosystems Receives Multi-System Order from Samsung Biologics to Expand Growth Direct Platform for Microbial Quality Control Automation - Quiver Quantitative

Quiver Quantitative - Mar 12, 2026

Direct Biologics Announces New Advanced Tool in Regenerative Medicine with Launch of AmnioWrap™ Placental Allograft - Newswire.com

Newswire.com - Jan 12, 2021

Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline - PR Newswire

PR Newswire - Dec 12, 2025

Direct Biologics - The Pharmaletter

The Pharmaletter - Jun 30, 2024

Direct Biologics Receives FDA Approval to Initiate ‘EXIT COVID-19,’ a Phase II Investigational New Drug Trial with ExoFlo™ - BioInformant

BioInformant - Aug 02, 2020

For Nascent Exosome Field, One Company’s Win Is Everyone’s Gain - Citeline News & Insights

Citeline News & Insights - Sep 30, 2024

Direct Biologics Reveals Successful Outcomes from EXIT COVID-19 Phase II Clinical Trial - PR Newswire UK

PR Newswire UK - Apr 06, 2022

APEX Biologix, LLC Announces Agreement With New Exosome Supplier - Newswire.com

Newswire.com - Sep 19, 2019

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment